Here are two stocks with buy rank and strong value characteristics for investors to consider today, March 4th:
Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
Catalyst Pharmaceuticals has a price-to-earnings ratio (P/E) of 8.49 compared with 22.04 for the S&P. The company possesses a Value Score of A.
Catalyst Pharmaceuticals, Inc. PE Ratio (TTM)
Catalyst Pharmaceuticals, Inc. pe-ratio-ttm | Catalyst Pharmaceuticals, Inc. Quote
XP XP: This technology-driven financial services platform, which offers financial products and services primarily in Brazil, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
XP Inc. Price and Consensus
XP Inc. price-consensus-chart | XP Inc. Quote
XP has a price-to-earnings ratio (P/E) of 10.06 compared with 22.04 for the S&P. The company possesses a Value Score of A.
XP Inc. PE Ratio (TTM)
XP Inc. pe-ratio-ttm | XP Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Free Report: Profiting from the 2nd Wave of AI Explosion
The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.
Investors who bought shares like Nvidia at the right time have had a shot at huge gains.
But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.
Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.
Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Catalyst Pharmaceuticals, Inc. (CPRX): Free Stock Analysis Report
XP Inc. (XP): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).